New Jersey legislation · 2026-2027 Regular Session
New Jersey A5062: Alzheimer's disease & related disorders-req coverage for testing & treatments
Status: Passed one chamber, September 28, 2026
Requires health insurance and Medicaid coverage for testing and treatments to slow progression of Alzheimer's disease and related disorders.
What the bill says
An Act concerning health insurance coverage for Alzheimer's disease and supplementing various parts of the statutory law.
From the introduced text, May 14, 2026:
An Act concerning health insurance coverage for Alzheimer's disease and supplementing various parts of the statutory law. Be It Enacted by the Senate and General Assembly of the State of New Jersey: 1. a. A hospital service corporation contract that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1938, c.366 (C.17:48-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for all medically necessary diagnostic testing and U.S. Food and Drug Administration-approved treatments or medications prescribed to slow the progression of Alzheimers disease and related disorders, in accordance with the U.S. Food and Drug Administration label, as determined by a physician. b. The benefits shall be provided to the same extent as for any other condition under the contract, except that coverage of U.S. Food and Drug Administration-approved treatments or medications prescribed to slow the progression of Alzheimer's disease or another related disorder pursuant to this section shall not be subject to any step therapy requirements. c. This section shall apply to those hospital service corporation contracts in which the hospital service corporation has reserved the right to change the premium. 2. a. A medical service corporation contract that …
Sponsors
- Carol A. Murphy (D, 7) · primary sponsor
- Tennille R. McCoy (D, 14) · primary sponsor
- Robert J. Karabinchak (D, 18) · primary sponsor
- Shama A. Haider (D, 37)
- William B. Sampson, IV (D, 31)
- Anthony Angelozzi (D, 8)
- Katie Brennan (D, 32)
- Clinton Calabrese (D, 36)
- Annette Quijano (D, 20)
- Verlina Reynolds-Jackson (D, 15)
- Dan Hutchison (D, 4)
- Luanne M. Peterpaul, Esq. (D, 11)
Latest actions
- : R/S REF SCM
- : PA (78-0-1)
- : REP 2RA
- : TRANS AAP
- : INT 1RA REF AFI
Votes
- 3RDG FINAL PASSAGE - Alzheimer's disease & related disorders-req coverage for testing & treatments (June 30, 2026): 78 yea, 0 nay, passed
- Assembly Appropriations Committee: Reported favorably (June 23, 2026): 14 yea, 0 nay, passed
Subjects: HEALTH - DISEASE, HUMAN SERVICES - MEDICAID AND MEDICARE
Common questions
- What is A5062?
- A5062 is a bill in the New Jersey Legislature (2026-2027 Regular Session): Alzheimer's disease & related disorders-req coverage for testing & treatments.
- What does A5062 do?
- In its own words: An Act concerning health insurance coverage for Alzheimer's disease and supplementing various parts of the statutory law.
- What is the status of A5062?
- Passed one chamber as of September 28, 2026. Latest action: R/S REF SCM (September 28, 2026).
- Who sponsored A5062?
- Carol A. Murphy (D, 7), with 11 co-sponsors.
- Where is the official record for A5062?
- On the New Jersey Legislature website: https://www.njleg.state.nj.us/bill-search/2026/A5062
Source: official New Jersey record. Tracked by Delilah, AI for legislation across all 50 states and Congress.